AOBiome
AOBiome develops topical microbiome therapeutics based on ammonia-oxidizing bacteria for inflammatory skin conditions, including atopic dermatitis and acne. Its lead candidate, B244, is in clinical development.
Key facts
| Company Operating Status | Active |
|---|---|
| Full Address | 125 Cambridgepark Drive Cambridge, MA 02140 |
| Wellfound ID | aobiome |
Contact details
Email and phone for AOBiome are available to signed-in members of CliffBio.
Sign in to view